• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于互联网的炎症性肠病患者队列的开发(CCFA 合作伙伴):方法学和初步结果。

Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.

机构信息

University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599, USA.

出版信息

Inflamm Bowel Dis. 2012 Nov;18(11):2099-106. doi: 10.1002/ibd.22895. Epub 2012 Jan 27.

DOI:10.1002/ibd.22895
PMID:22287300
Abstract

BACKGROUND

The widespread use of the Internet allows for unique research opportunities. We aimed to develop and follow an Internet-based cohort (e-cohort) of patients with self-reported inflammatory bowel diseases (IBD) over time.

METHODS

We established an e-cohort of adults with IBD (CCFA Partners) by recruiting through Crohn's and Colitis Foundation of America (CCFA) email rosters, CCFA Website promotion, social media, and other publicity mechanisms. The baseline survey included modules on disease course and activity, diet and exercise, and patient-reported outcomes (PROs). Baseline characteristics of the cohort are summarized using descriptive statistics.

RESULTS

A total of 7819 adults with IBD joined CCFA Partners through August, 2011. The median age was 42 years (interquartile range [IQR] 30-54), 5074 (72.3%) were female. A total of 4933 (63.1%) had Crohn's disease (CD), 2675 (34.2%) had ulcerative colitis (UC), and 211 (2.7%) had IBD unspecified. For CD, the mean short CD Activity Index (CDAI) was 151.9 (standard deviation [SD] 106.4), with 2274 (59.4%) in remission. For UC, the mean simple clinical colitis activity index (SCCAI) was 3.6 (SD 2.8), with 937 (42.9%) in remission. The mean short IBD questionnaire (SIBDQ) score was 48.7 (SD 11.8). SIBDQ was inversely correlated with disease activity (P < 0.01). The mean Morisky medication adherence score (MMAS) was 5.7 (SD 2.0). MMAS scores were inversely correlated with disease activity (P < 0.01).

CONCLUSIONS

CCFA Partners is a novel e-cohort. Enrollment is ongoing, with surveys twice yearly. CCFA Partners represents a unique resource to study PROs and changes in disease management over time.

摘要

背景

互联网的广泛使用为研究提供了独特的机会。我们的目的是建立并跟踪一个基于互联网的、有自我报告炎症性肠病(IBD)的患者队列(电子队列,e-cohort)。

方法

我们通过招募美国克罗恩病和结肠炎基金会(CCFA)的电子邮件名单、CCFA 网站宣传、社交媒体和其他宣传机制,建立了一个成年人 IBD 的电子队列(CCFA 合作伙伴)。基线调查包括疾病过程和活动、饮食和运动以及患者报告的结果(PROs)模块。使用描述性统计总结队列的基线特征。

结果

截至 2011 年 8 月,共有 7819 名成年人加入了 CCFA 合作伙伴。中位年龄为 42 岁(四分位距 [IQR] 30-54),5074 名(72.3%)为女性。共有 4933 名(63.1%)患有克罗恩病(CD),2675 名(34.2%)患有溃疡性结肠炎(UC),211 名(2.7%)患有未特指的 IBD。对于 CD,平均简短 CD 活动指数(CDAI)为 151.9(标准差 [SD] 106.4),2274 名(59.4%)处于缓解状态。对于 UC,平均简单临床结肠炎活动指数(SCCAI)为 3.6(SD 2.8),937 名(42.9%)处于缓解状态。平均简短 IBD 问卷(SIBDQ)评分为 48.7(SD 11.8)。SIBDQ 与疾病活动呈负相关(P<0.01)。平均 Morisky 药物依从性评分(MMAS)为 5.7(SD 2.0)。MMAS 评分与疾病活动呈负相关(P<0.01)。

结论

CCFA 合作伙伴是一个新颖的电子队列。入组仍在进行中,每年进行两次调查。CCFA 合作伙伴代表了一个独特的资源,可以研究 PROs 和随着时间的推移疾病管理的变化。

相似文献

1
Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results.基于互联网的炎症性肠病患者队列的开发(CCFA 合作伙伴):方法学和初步结果。
Inflamm Bowel Dis. 2012 Nov;18(11):2099-106. doi: 10.1002/ibd.22895. Epub 2012 Jan 27.
2
Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.实现协同效应:将基于互联网的炎症性肠病队列与基于社区的起始队列以及炎症性肠病多中心队列相联系。
J Med Internet Res. 2016 Jun 3;18(6):e124. doi: 10.2196/jmir.5655.
3
Validation of an internet-based cohort of inflammatory bowel disease (CCFA partners).基于互联网的炎症性肠病队列的验证(CCFA 合作伙伴)。
Inflamm Bowel Dis. 2014 Mar;20(3):541-4. doi: 10.1097/01.MIB.0000441348.32570.34.
4
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.睡眠障碍与克罗恩病和溃疡性结肠炎患者活动期疾病的风险。
Clin Gastroenterol Hepatol. 2013 Aug;11(8):965-71. doi: 10.1016/j.cgh.2013.01.021. Epub 2013 Feb 1.
5
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.克罗恩病和溃疡性结肠炎。欧洲一项基于人群的起始队列研究中疾病第一年的发病率、病程及预后
Dan Med J. 2014 Jan;61(1):B4778.
6
Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.炎症性肠病-肠易激综合征在CCFA合作伙伴中对患者报告结局的患病率及影响
Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.
7
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.CD4+ 免疫反应作为患者报告的炎症性肠病 (IBD) 活动的潜在生物标志物。
Clin Chim Acta. 2013 Jun 5;421:31-3. doi: 10.1016/j.cca.2013.02.016. Epub 2013 Feb 26.
8
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.一种用于日常临床的患者报告的炎症性肠病活动度简单0至10数值评分(IBD-10)的验证
Inflamm Bowel Dis. 2016 Aug;22(8):1902-7. doi: 10.1097/MIB.0000000000000803.
9
Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners).利用个人生成的健康数据加速以患者为中心的结果研究:美国克罗恩病和结肠炎基金会PCORnet患者驱动研究网络(CCFA合作伙伴)。
J Am Med Inform Assoc. 2016 May;23(3):485-90. doi: 10.1093/jamia/ocv191. Epub 2016 Jan 28.
10
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.《简短炎症性肠病问卷:用于社区医生管理炎症性肠病的生活质量工具》。CCRPT研究人员。加拿大克罗恩病复发预防试验。
Am J Gastroenterol. 1996 Aug;91(8):1571-8.

引用本文的文献

1
Perspectives on Contraception, Pregnancy, and Reproductive Health Counseling from Young Women With Inflammatory Bowel Disease.炎症性肠病青年女性对避孕、妊娠及生殖健康咨询的观点
Crohns Colitis 360. 2024 Dec 20;7(1):otae078. doi: 10.1093/crocol/otae078. eCollection 2025 Jan.
2
mHealth Physical Activity and Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases: Cluster Analysis.移动医疗在炎症性肠病患者中的体力活动和患者报告结局:聚类分析。
J Med Internet Res. 2024 Sep 24;26:e48020. doi: 10.2196/48020.
3
Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data.
患有肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)和关节过度活动综合征的人是否代表一个疾病亚组?一项基于登记数据的分析。
Front Neurol. 2024 Mar 13;15:1324879. doi: 10.3389/fneur.2024.1324879. eCollection 2024.
4
The Comorbidity of Patient-Reported Crohn's Disease Activity and Depression: The Role of Health Behavior Mediators.患者报告的克罗恩病活动与抑郁症的共病:健康行为中介因素的作用
Crohns Colitis 360. 2023 Dec 23;6(1):otad080. doi: 10.1093/crocol/otad080. eCollection 2024 Jan.
5
Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT.基于网络的视频教育提高炎症性肠病成人对流感疫苗接种和其他预防保健建议的接受度:预防项目的随机对照试验。
J Med Internet Res. 2023 Aug 23;25:e42921. doi: 10.2196/42921.
6
Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort.溃疡性结肠炎与 IBD 伙伴关系队列中饮食相关炎症和身体活动有关。
Inflamm Bowel Dis. 2024 Feb 1;30(2):273-280. doi: 10.1093/ibd/izad139.
7
Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.比较溃疡性结肠炎抗TNF治疗经验丰富的患者起始维多珠单抗与托法替布治疗后的患者报告结局
Crohns Colitis 360. 2023 May 29;5(3):otad031. doi: 10.1093/crocol/otad031. eCollection 2023 Jul.
8
Computerized-adaptive testing versus short forms for pediatric inflammatory bowel disease patient-reported outcome assessment.计算机自适应测试与简表用于儿科炎症性肠病患者报告结局评估的比较
J Clin Transl Sci. 2023 Apr 14;7(1):e109. doi: 10.1017/cts.2023.526. eCollection 2023.
9
Comparing Patient-Reported Outcomes Among Anti-TNF-Experienced Patients with Crohn's Disease Initiating Vedolizumab Versus Ustekinumab.比较抗 TNF 经验丰富的克罗恩病患者中,起始使用维得利珠单抗与乌司奴单抗的患者报告结局。
Dig Dis Sci. 2023 Aug;68(8):3413-3420. doi: 10.1007/s10620-023-07942-0. Epub 2023 Apr 28.
10
Adjunctive Pharmacotherapy Use in Patients With Ileal Pouch-Anal Anastomosis (IPAA).回肠储袋肛管吻合术(IPAA)患者的辅助药物治疗应用
Crohns Colitis 360. 2020 Oct 28;2(4):otaa091. doi: 10.1093/crocol/otaa091. eCollection 2020 Oct.